CorpDigest
Aflac Incorporated
Leadership History
3 leaders · Full leadership timeline
Last reviewed: 2026-06-10 · By Swet Parvadiya
More than half of all Japanese people with cancer insurance hold a policy from Aflac. The portfolio yield of approximately 4.8 percent, up roughly 30 basis points year-over-year, reflects the benefit of the higher-interest-rate environment for an insurer with long-duration asset holdings. The Japanese yen's exchange rate movements affect how Aflac's Japanese earnings translate into U.S. Dollar reported results, and yen depreciation in recent years has reduced the dollar value of Japan segment earnings relative to what the underlying yen figures imply. The early years were modest. The Japan expansion in 1974 was counterintuitive. The market penetration that followed was unlike anything Aflac had achieved domestically. The company returns capital to shareholders consistently through dividends and buybacks, and the Japanese business's cash flows are predictable enough to support that return even in years when U.S. Claims activity is elevated. John, Paul, and Bill Amos incorporated American Family Life Assurance Company in Columbus, Georgia in 1955 with $150,000 in capital and a plan to sell health insurance policies in the workplace rather than door-to-door. The company sold cancer insurance — policies that paid cash benefits directly to the policyholder upon a cancer diagnosis, regardless of other insurance coverage — and built its distribution network through independent agents trained in worksite selling. The cancer insurance product addressed a gap in standard health insurance: even with coverage, a cancer diagnosis generated out-of-pocket costs, lost income, and financial disruption that a cash benefit could partially offset. By the time the Aflac duck arrived in 2000, the company had been public for nearly thirty years and had established Japan as its primary profit engine. The American advertising campaign solved a domestic awareness problem while the Japanese business quietly generated the majority of the company's earnings from a market most American investors had never thought to examine.
Chief Executive Officer
Massey has led Aflac's strategic focus on digital transformation and AI integration, driving operational efficiency and expanding the company's voluntary benefits portfolio in the US market while navigating the demographic challenges in Japan.
President
Dugger oversees Aflac's US operations, focusing on strengthening the worksite distribution model, enhancing agent productivity through digital tools, and defending the company's market share against intense competition from major medical insurers.
Chief Financial Officer
Ziegenhorn manages Aflac's massive $160 billion investment portfolio and capital allocation strategy, successfully navigating the higher-interest-rate environment to maximize net investment income and fund aggressive share repurchases.
The duck's quacking of "Aflac" in situations where people couldn't remember the company's name was a self-aware joke about brand awareness that simultaneously solved the brand awareness problem. Currency risk is the structural variable most often cited in Aflac's risk disclosures. The Japanese model relies heavily on a direct sales force and a network of agency shops, rather than the employer-based worksite model used in the US, and it benefits from the cultural emphasis on financial preparedness and the demographic reality of an aging population that is acutely aware of the financial risks associated with cancer. Additionally, Aflac's worksite distribution model, which has been the foundation of its US success for decades, is facing challenges in a post-pandemic environment where remote and hybrid work arrangements have reduced the opportunities for agents to present products to large groups of employees in the workplace.
The irony is, the company's reliance on a network of independent agents in the US also presents a challenge, as the gig economy and changing labor pattern make it increasingly difficult to recruit and retain high-quality sales representatives, forcing Aflac to enhance its agent compensation packages and provide advanced digital tools to maintain its competitive edge in the labor market. The company's proprietary actuarial models, which incorporate decades of claims data from millions of policyholders across two distinct healthcare systems, provide a predictive accuracy that allows Aflac to price risk more accurately than newer entrants who lack the historical depth to model long-tail supplemental claims with precision. Aflac is also using its vast historical claims data to develop more personalized and targeted product offerings, using predictive analytics to identify policyholders who are at higher risk for certain conditions and offering them tailored coverage options.
Daniel P. Amos, son of co-founder John Amos, served as CEO from 1990 to 2023 — a 33-year tenure that transformed Aflac from a regional US insurer into an international company with $17+ billion in revenue. His most defining decision was greenlit the Duck campaign in 2000, which drove US brand awareness from under 15% to over 90%. He also oversaw Aflac's evolution from cancer-specific to a full supplemental benefit suite and navigated the Japan yen exposure through multiple exchange rate cycles.
In 2023, Daniel Amos transitioned from CEO to Executive Chairman, with Frederick Crawford becoming Chairman of the Board and Daniel Massey named CEO. This was the first time Aflac was led by a non-Amos family CEO. Crawford had served as Aflac's CFO and was known as the architect of Aflac's capital return strategy. Massey, previously President of Aflac US, came up through the company's sales and operations leadership, providing continuity in distribution strategy.
Daniel Massey spent his career at Aflac, rising through US sales management to become President of Aflac US before CEO succession. His priorities include accelerating Aflac's US growth through digital enrollment platforms and employer benefit market expansion, maintaining Aflac Japan's leadership despite demographic headwinds (aging population reduces new policy sales), and managing yen-dollar exposure more actively. He has also emphasized AI investment for claims processing and underwriting efficiency.
Frederick Crawford served as Aflac's CFO from 2019 to 2023 and was the primary architect of Aflac's disciplined capital allocation framework — balancing aggressive buybacks ($2B+ annually) with investment portfolio management and strategic acquisitions. He oversaw Aflac's financial communication during COVID-19 (explaining the claim rate decline), navigated yen-dollar headwinds transparently with investors, and built credibility with the institutional investor base that supported Aflac's Dividend Aristocrat status.